cilostazol has been researched along with Diabetic Neuropathies in 10 studies
Diabetic Neuropathies: Peripheral, autonomic, and cranial nerve disorders that are associated with DIABETES MELLITUS. These conditions usually result from diabetic microvascular injury involving small blood vessels that supply nerves (VASA NERVORUM). Relatively common conditions which may be associated with diabetic neuropathy include third nerve palsy (see OCULOMOTOR NERVE DISEASES); MONONEUROPATHY; mononeuropathy multiplex; diabetic amyotrophy; a painful POLYNEUROPATHY; autonomic neuropathy; and thoracoabdominal neuropathy. (From Adams et al., Principles of Neurology, 6th ed, p1325)
| Excerpt | Relevance | Reference |
|---|---|---|
| " Safety parameters were changes in nerve conduction studies as well as reporting of adverse events." | 6.76 | Cilostazol: a pilot study on safety and clinical efficacy in neuropathies of diabetes mellitus type 2 (ASCEND). ( Mercado-Asis, LB; Rosales, RL; Santos, MM, 2011) |
| " Safety parameters were changes in nerve conduction studies as well as reporting of adverse events." | 2.76 | Cilostazol: a pilot study on safety and clinical efficacy in neuropathies of diabetes mellitus type 2 (ASCEND). ( Mercado-Asis, LB; Rosales, RL; Santos, MM, 2011) |
| "Cilostazol treatment not only restored myelinated fiber density and size distribution but reversed some of the vascular abnormalities." | 1.30 | Effect of cilostazol on the neuropathies of streptozotocin-induced diabetic rats. ( Choi, YK; Kim, JW; Kim, SW; Kim, YS; Oh, SJ; Park, IK; Suh, KS; Woo, JT; Yang, IM, 1999) |
| "Cilostazol treatment (30 mg/kg/day p." | 1.29 | Effects of cilostazol on development of experimental diabetic neuropathy: functional and structural studies, and Na+ -K+ -ATPase acidity in peripheral nerve in rats with streptozotocin-induced diabetes. ( Furuta, M; Kishi, Y; Mukoyama, M; Naka, K; Nanjo, K; Sanke, T; Sasaki, H, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (70.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asal, NJ | 1 |
| Wojciak, KA | 1 |
| Papanas, N | 1 |
| Maltezos, E | 1 |
| Rosales, RL | 1 |
| Santos, MM | 1 |
| Mercado-Asis, LB | 1 |
| Kihara, M | 1 |
| Schmelzer, JD | 1 |
| Low, PA | 1 |
| Naka, K | 1 |
| Sasaki, H | 1 |
| Kishi, Y | 1 |
| Furuta, M | 1 |
| Sanke, T | 1 |
| Nanjo, K | 1 |
| Mukoyama, M | 1 |
| Hotta, N | 1 |
| Koh, N | 1 |
| Sakakibara, F | 1 |
| Nakamura, J | 1 |
| Hamada, Y | 1 |
| Hara, T | 1 |
| Mori, K | 1 |
| Naruse, K | 1 |
| Fukasawa, H | 1 |
| Kakuta, H | 1 |
| Sakamoto, N | 1 |
| Yamamoto, Y | 1 |
| Yasuda, Y | 1 |
| Kimura, Y | 1 |
| Komiya, Y | 1 |
| Omoto, S | 1 |
| Nomura, S | 1 |
| Shouzu, A | 1 |
| Hayakawa, T | 1 |
| Shimizu, H | 1 |
| Miyake, Y | 1 |
| Yonemoto, T | 1 |
| Nishikawa, M | 1 |
| Fukuhara, S | 1 |
| Inada, M | 1 |
| Suh, KS | 1 |
| Oh, SJ | 1 |
| Woo, JT | 1 |
| Kim, SW | 1 |
| Yang, IM | 1 |
| Kim, JW | 1 |
| Kim, YS | 1 |
| Choi, YK | 1 |
| Park, IK | 1 |
| Okuda, Y | 1 |
| Mizutani, M | 1 |
| Ikegami, T | 1 |
| Ueno, E | 1 |
| Yamashita, K | 1 |
2 reviews available for cilostazol and Diabetic Neuropathies
| Article | Year |
|---|---|
Effect of cilostazol in treating diabetes-associated microvascular complications.
Topics: Cilostazol; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Neuropathies; Humans; Tetrazoles | 2017 |
Cilostazol in diabetic neuropathy: premature farewell or new beginning?
Topics: Cilostazol; Diabetic Neuropathies; Humans; Phosphodiesterase 3 Inhibitors; Tetrazoles; Treatment Out | 2011 |
1 trial available for cilostazol and Diabetic Neuropathies
| Article | Year |
|---|---|
Cilostazol: a pilot study on safety and clinical efficacy in neuropathies of diabetes mellitus type 2 (ASCEND).
Topics: Adolescent; Adult; Aged; Cilostazol; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Dose-Response | 2011 |
7 other studies available for cilostazol and Diabetic Neuropathies
| Article | Year |
|---|---|
Effect of cilostazol on experimental diabetic neuropathy in the rat.
Topics: Animals; Blood Glucose; Blood Pressure; Body Weight; Cilostazol; Diabetes Mellitus, Experimental; Di | 1995 |
Effects of cilostazol on development of experimental diabetic neuropathy: functional and structural studies, and Na+ -K+ -ATPase acidity in peripheral nerve in rats with streptozotocin-induced diabetes.
Topics: Animals; Blood Glucose; Body Weight; Cilostazol; Cyclic AMP; Diabetes Mellitus, Experimental; Diabet | 1995 |
Nerve function and blood flow in Otsuka Long-Evans Tokushima Fatty rats with sucrose feeding: effect of an anticoagulant.
Topics: 2,3-Diphosphoglycerate; Alcohols; Animals; Anticoagulants; Blood Glucose; Body Weight; Carbohydrate | 1996 |
Effects of cilostazol, an antiplatelet agent, on axonal regeneration following nerve injury in diabetic rats.
Topics: Animals; Axons; Blood Glucose; Body Weight; Cilostazol; Diabetes Mellitus, Experimental; Diabetic Ne | 1998 |
Significance of platelet-derived microparticles and activated platelets in diabetic nephropathy.
Topics: Antigens, CD; Blood Coagulation; Blood Platelets; Case-Control Studies; Cilostazol; Diabetic Nephrop | 1999 |
Effect of cilostazol on the neuropathies of streptozotocin-induced diabetic rats.
Topics: Animals; Cilostazol; Cyclic AMP; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Male; Neura | 1999 |
Hemodynamic effects of cilostazol on peripheral artery in patients with diabetic neuropathy.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aged; Arteries; Blood Glucose; Cilostazol; Diabetic Neuropathie | 1992 |